Home / BUSINESS / USFDA completes audit of Dr. Reddy’s Andhra Pradesh facility

USFDA completes audit of Dr. Reddy’s Andhra Pradesh facility

The US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy’s Laboratories’ Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh on November 16, 2018 with zero observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Please share this news